By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Apotex Inc. 

150 Signet Drive

Toronto  Ontario  M9L 1T9  Canada
Phone: 416-749-9300 or 800-268-4623 Fax: 416-401-3835




Company News
Apotex Inc. Release: Setting The Record Straight: Products Are Safe And Effective 9/26/2014 9:53:34 AM
Information Update - Health Canada Requests Quarantine Of Products For Canadian Market From Apotex Inc. Facility In Bangalore, India 9/25/2014 7:48:02 AM
Apotex Inc. Release: Medicine To Treat 1 In 10 Haitians Arrives In Port-au-Prince 9/11/2014 8:13:11 AM
Appointment Announcement - Dr. Jeremy B. Desai, President and CEO, Apotex Inc. 8/27/2014 7:22:06 AM
Apotex Inc. Release: NAFTA Tribunal Decision Supports FDA And Its Actions 8/26/2014 9:29:10 AM
Apotex Inc. Recalls One Lot Of Organ Rejection Drug Apo-Mycophenolic Acid Due To Label Error 8/18/2014 6:21:54 AM
Apotex Inc. Ordered To Pony Up $76 Million To AstraZeneca PLC (AZN) In Damages 12/4/2013 6:55:59 AM
Apotex Inc. is in the FDA Dog House, Again 3/20/2013 7:45:54 AM
Nuvo Research Inc. (NRI.TO) Announces Settlement Agreement With Apotex Inc. in PENNSAID® Generic Litigation 1/29/2013 9:15:45 AM
Supreme Court Denies Apotex Inc.'s Petition for a Writ of Certiorari 3/22/2012 10:06:45 AM